Ultrasound in Medicine and Biology
Volume 28, Issue 4 , Pages 445-451 , April 2002

Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results

  • Flemming Forsberg

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Flemming Forsberg, Ph.D., Department of Radiology, Division of Ultrasound, Suite 763J, Main Building, 132 South 10th Street, Philadelphia, PA, 19107 USA
    • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA
    • ,
  • Adam P. Dicker

      Affiliations

    • Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA
    • ,
  • Mattew L. Thakur

      Affiliations

    • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA
    • ,
  • Nandkumar M. Rawool

      Affiliations

    • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA
    • ,
  • Ji-bin Liu

      Affiliations

    • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA
    • ,
  • William T. Shi

      Affiliations

    • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA
    • ,
  • Levon N. Nazarian

      Affiliations

    • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA

Received 17 September 2001 ,Accepted 9 January 2002.

References 

  1. Albrecht T, Hoffman CW, Schettler S, et al.  B-mode enhancement using phase-inversion US with air-based microbubble contrast agent (Initial experience in humans). Radiology. 2000;216:273–278
  2. Bland JM, Altman DG. Multiple significance tests (The Bonferroni method). Br Med J. 1995;310:170
  3. Brawer MK, Bigler SA, Deering RE. Quantitative morphometric analysis of the microcirculation in prostate carcinoma. J Cell Biochem. 1992;16H(Suppl.):62–64
  4. Broillet A, Puginier J, Ventrone R, Schneider M. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent. Invest Radiol. 1998;33:209–215
  5. Capizzi RL, De Moraes E, Grant D, et al.  Development of surrogate markers of response for antiangiogenic therapies utilizing non-invasive and invasive assessments of tumor angiogenesis (Abstr.). Proc Am Soc Clin Oncol. 2001;20:2090
  6. Chaudhari MH, Forsberg F, Voodarla A, et al.  Breast tumor vascularity identified by contrast enhanced ultrasound and pathology (Initial results). Ultrasonics. 2000;38:105–109
  7. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part one (Simulations). Ultrasonics. 1994;32:447–453
  8. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part two (Measurements). Ultrasonics. 1994;32:455–459
  9. Denkert C, Köbel M, Berger S, et al.  Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res. 2001;61:303–308
  10. Dinney CP, Bielenberg DR, Perrotte P, et al.  Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res. 1998;58:808–814
  11. Donnelly EF, Geng L, Wojcicki WE, Fleicher AC, Hallahan DE. Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology. 2001;219:166–170
  12. Ferrara KF, Merritt CRB, Burns PN, Foster S, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US (Imaging, Doppler and contrast agents). Acad Radiol. 2000;7:824–839
  13. Fidler IJ. Angiogenic heterogeneity (Regulation of neoplastic angiogenesis by the organ microenvironment). J Natl Cancer Inst. 2001;93:1040–1041
  14. Fleicher AC. Sonographic depiction of tumor vascularity and flow from in vivo models to clinical applications. J Ultrasound Med. 2000;19:55–61
  15. Fleicher AC, Wojcicki WE, Donnelly EF, et al.  Quantified color Doppler sonography of tumor vascularity in an animal model. J Ultrasound Med. 1999;18:547–551
  16. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1990;82:4–6
  17. Folkman J, Hahnfeldt P, Hlatky L. The logic of anti-angiogenic gene therapy. Target tissues and target diseases—Cancer. Plainview, NY: Cold Spring Harbor Laboratory Press; 1998;
  18. Folkman J, Meerler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971;33:275–278
  19. Forsberg F, Goldberg BB, Liu JB, Merton DA, Rawool NM. On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres. J Ultrasound Med. 1996;15:853–860
  20. Forsberg F, Liu JB, Chiou HJ, Rawool NM, Parker L, Goldberg BB. Comparison of fundamental and wideband harmonic contrast imaging of liver tumors. Ultrasonics. 2000;38:110–113
  21. Forsberg F, Merton DA, Liu JB, Needleman L, Goldberg BB. Clinical applications of ultrasound contrast agents. Ultrasonics. 1998;36:695–701
  22. Forsberg F, Shi WT, Merritt CRB, Solcova M, Dai Q, Goldberg BB. Does the mechanical index predict destruction rates for contrast microbubbles?. (Abstr.) J Ultrasound Med. 2001;20:S12–S13
  23. Grischke EM, Kaufmann M, Eberlein-Gonska M, Mattfeldt T, Sohn C, Bastert G. Angiogenesis as a diagnostic factor in primary breast cancer (Microvessel quantitation by stereological methods and correlation with color Doppler sonography). Onkologie. 1994;17:35–42
  24. Holmgren L, O’Reilly MS, Folkman J. Dormancy of micrometastases (Balanced proliferation and apoptosis in the presence of angiogenesis suppression). Nature Med. 1995;1:149–153
  25. Hope Simpson D, Chin CT, Burns PN. Pulse inversion Doppler (A new method for detecting nonlinear echoes from microbubble contrast agents). IEEE Trans Ultrason Ferroelec Freq Control. 1999;46:372–382
  26. Jain RK. Determination of tumor blood flow (A review). Cancer Res. 1988;48:2641–2658
  27. Junger M, Steins A, Schlagenhauff B, Rassner G. Microcirculation of cutaneous melanoma. in German Hautarzt. 1999;50:848–852
  28. Leahy KM, Koki AT, Masferrer JL. Role of cyclooxygenases in angiogenesis. Curr Med Chem. 2000;7:1163–1170
  29. Li J, Merton DA, Duggaraju R, Thakur ML. Augmenting of tumor uptake of anti-melanoma antibody MEM136 (Influence of interferon). Nucl Med Biol. 1996;23:873–879
  30. Masferrer JL, Leahy KM, Koki AT, et al.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 2000;60:1306–1311
  31. Obermair A, Kucera E, Mayerhofer K, et al.  Vascular endothelial growth factor (VEGF) in human breast cancer (Correlation with disease-free survival). Int J Cancer. 1997;74:455–458
  32. Perneger TV. What’s wrong with Bonferroni adjustments. Br Med J. 1998;316:1236–1238
  33. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Circulation. 1995;92:2391–2395
  34. Reinhold HS, van den Berg-Blok A. Factors influencing the neovascularization of experimental tumours. Biorheology. 1984;21:493–501
  35. Relf M, LeJeune S, Scott PA, et al.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 1997;57:963–969
  36. Rooks V, Beecken WD, Iordanescu I, Taylor GA. Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP-470, an angiogenesis inhibitor. Acad Radiol. 2001;8:121–127
  37. Saunders M, Gee MS, Sehgal CM, Lee JC, Feldman M, Lee WM. Evaluating power Doppler ultrasound as a method for clinical monitoring of tumor antiangiogenic therapy. (Abstr.) Radiology. 2000;217(P):396
  38. Schor AM, Schor SL. Tumour angiogenesis. J Pathol. 1983;141:385–413
  39. Schroeder RF, Hauff P, Bartels T, et al.  Tumor vascularization in experimental melanomas (Correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading). Ultrasound Med Biol. 2001;27:761–771
  40. Stucker M, Horstmann I, Nuchel C, Rochling A, Hoffmann K, Altmeyer P. Blood flow compared in benign melanocytic naevi, malignant melanomas and basal cell carcinomas. Clin Exp Dermatol. 1999;24:107–111
  41. Tur E, Brenner S. Cutaneous blood flow measurements for the detection of malignancy in pigmented skin lesions. Dermatology. 1992;184:8–11
  42. Wapnir IL, Barnard N, Wartenberg D, Greco RS. The inverse relationship between microvessel counts and tumor volume in breast cancer. Breast J. 2001;7:184–188
  43. Weidner N, Folkman J, Pozza F, et al.  Tumor angiogenesis (A new significant and independent prognostic indicator in early-stage breast cancer). J Natl Cancer Inst. 1992;84:1875–1887
  44. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8
  45. Weind KL, Maier CF, Rutt BK, Moussa M. Invasive carcinoma and fibroadenomas of the breast (Comparison of microvessel distributions—implications for imaging modalities). Radiology. 1998;208:477–483

PII: S0301-5629(02)00482-9

Ultrasound in Medicine and Biology
Volume 28, Issue 4 , Pages 445-451 , April 2002

Article Tools

* Image Usage & Resolution